Transforming growth factor beta-β (TGF-β)
Top PDF Transforming growth factor beta-β (TGF-β):
Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type beta receptors and the JNK pathway
... Transforming growth factor β (TGF-β) is a very strong pro-fibrotic factor which mediates its action, at least in part, through the expression of connective tissue growth ...
9
Signaling pathways involved in colorectal cancer progression
... mal growth factor; Fz: frizzled receptor; Grb2: growth factor receptor-bound protein 2; GS domain: glycine-serine repeats domain; Hey1: hairy/enhancer-of- split related with YRPW motif protein ...
14
Angiotensin (1 7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF β) via Mas Receptor Activation
... the decrease of the fibre diameters and MHC levels induced by TGF-β1 in the tibialis anterior (TA) of mice. (A) TA muscles of male C57/ BL10 mice were injected with either PBS (control) or TGF-β1 (10 ng) at day 1 and 3. ...
12
Angiogenesis and pancreatic cancer: a role for tissue plasminogen activator (tPA)
... Transforming Growth factor-beta (TGF-β) are family of homodimeric cytokines that help in controlling many different processes in the body, including ...EC growth, promotes ...
156
TítuloAlternative protocols to induce chondrogenic differentiation: transforming growth factor β superfamily
... and transforming growth factor beta (TGFβ) delivery, hypoxia has been indicated as crucial for complete ...the growth factor added to the culture ...three growth factors: ...
12
16641942
... human transforming growth factor- beta-1, genetically engineered to contain a collagen binding domain (rhTGF-β1-F2), or a commercial ...other growth factors in which the osteogenic ...
11
Estudio de factores biológicos implicados en el pronóstico del cáncer de mama mediante meta-análisis de datos publicados.
... insulin-like growth factor can be more important to produce an activation of the pathway than the mere presence of an increased amount of receptors ...
144
Estudio clínico multicéntrico del efecto de la aplicación de Células Mesenquimales de Grasa (CMG), Plasma Rico en Factores de Crecimiento (PRGF) y la combinación de ambos en el tratamiento de la enfermedad degenerativa articular en perro / tesis doctoral presentada por Belén Cuervo Serrato ; dirigida por [la] Dra Dña Mónica Rubio Zaragoza, [el] Dr D José María Carrillo Poveda [y el] Dr D Joaquín Jesús Sopena Juncosa
... del Factor de crecimiento derivado de las plaquetas (PDGF) y el Factor de crecimiento β transformante (TGF-β) desde la degranulación de las plaquetas del concentrado ...
459
Identificación de lactamasas de espectro extendido en enterobacterias aisladas de dos hospitales del estado de Guerrero, México
... de β-lactamasas de espectro extendido detectadas en los dos hospitales del Estado de Guerrero, representan una seria amenaza para la salud de los pacientes de ambos ...antibióticos beta- lactámicos en ...
35
The Latest in Peptides, Growth Factors, Cytokines, and Stem Cells
... topically. Growth factors pro- duced in ASCs can promote collagen synthesis by dermal ...53,54 Growth factors and other components found to be upregulated within the cultured medium can be found in Box 2 ...
9
Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD and p38 MAPK dependent mechanism in skeletal muscle
... 2 receptor in dystrophic skeletal muscle of mdx mice than in normal mice. The induction of AT-2 was mediated by the ca- nonical TGF-b pathway because under the inhibitory condi- tions of the kinase activity of TGFb ...
10
Transforming growth factor α immunoreactivity A study in hepatocellular carcinoma and in non neoplastic liver tissue
... 34. Chung YH, Kim JA, Song BC, Lee GC, Koh MS, Lee YS, Lee SG, et al. Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular ...
5
Adipose derived mesenchymal stem cells : are they a good therapeutic strategy for osteoarthritis? / Elena Damiá, Deborah Chicharro, Sergio López, Belén Cuervo, Mónica Rubio, Joaquín Sopena, José Manuel Vilar and José María Carrillo
... MSCs mesenchymal stem cells, BMMSCs bone marrow mesenchymal stem cells, OA osteoarthritis, TGF-β3 transforming growth factor β3, UCBMSCs umbilical cord blood mesenchymal stem cells, ASCs[r] ...
14
The Internal Region Leucine rich Repeat 6 of Decorin Interacts with Low Density Lipoprotein Receptor related Protein 1, Modulates Transforming Growth Factor (TGF) beta dependent Signaling, and Inhibits TGF beta dependent Fibrotic Response in Skeletal Muscles
... several growth fac- tors, including TGF-  ...insulin growth factor-1 and the insulin growth factor-1 receptor (20), resulting in insulin growth factor-1 receptor ...
16
08cap MI5aCD
... Para cierto laboratorio químicofarmacéutico (empresa), la R2 fue de 0.989 (0.988 corregida). Todos los pesos beta tuvieron una significancia menor al 0.01 (excepto recompensas, la cual fue de 0.175). Una vez más, ...
76
Estudi de la presenilina 1 com a inhibidor de l'activitat transcripcional de la ß (beta)-catenina
... la β- catenina i de la placoglobina (Figures 18 i ...la β- catenina és lògic pensar que hi hauria menys β-catenina nuclear i una disminució en la formació del complex Tcf-4·β-catenina i com a ...
185
Human conditions of insulin like growth factor I (IGF I) deficiency
... Finally, GH and IGF-I (both liver/endocrine and lo- cally produced) are essential for normal body growth. The role of other molecules for this control is also im- portant and may increase the complexity in the ...
29
El CIREN y la nueva neurologa
... Nerve growth factor improves evoked potentials and long- term potentiation in the dentate gyrus of presenile rats. Nerve growth factor and striatal glutathione metabolism i[r] ...
15
![Diseño de nanopartículas conteniendo β[Beta]-glucuronidasa con potencial uso en terapia enzimática directa](https://data02.123doks.com/thumbv2/123dok_es/001/100/1100774/cover.webp)
Diseño de nanopartículas conteniendo β[Beta]-glucuronidasa con potencial uso en terapia enzimática directa
... tecnología del hibridoma, los anticuerpos monoclonales se han convertido en una exitosa herramienta en la clínica para el tratamiento de numerosas enfermedades, entre ellas el cáncer. En efecto, la Administración de ...
95
Premios Sociedad Espaola de Diabetes 2009
... células beta a concentraciones elevadas de glu- cosa y ácidos grasos produciría una disfunción celular que culmi- naría en procesos de muerte celular, lo que se conoce como glu- colipotoxicidad ...
5